PTGS2 and neoplasm: More recently, Cox-2 overexpression has been identified in a number of different malignancies and it has been hypothesised that Cox-2 prostaglandins promote tumourigenesis by inhibiting apoptosis, modulating the immune system and regulating tumour-associated angiogenesis (Cha and DuBois, 2007).